PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics
Background Macrolides are a class of broad-spectrum antibiotics of large molecular size.
The class includes erythromycin, clarithromycin, and azithromycin, among others 1 …
The class includes erythromycin, clarithromycin, and azithromycin, among others 1 …
The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview
R Jain, LH Danziger - Current pharmaceutical design, 2004 - ingentaconnect.com
The macrolide antimicrobial family is a comprised of 14, 15 and 16 member-ringed
compounds that are characterized by similar chemical structures, mechanisms of action and …
compounds that are characterized by similar chemical structures, mechanisms of action and …
Clinical pharmacokinetic properties of the macrolide antibiotics: effects of age and various pathophysiological states (part I)
P Periti, T Mazzei, E Mini, A Novelli - Clinical pharmacokinetics, 1989 - Springer
The pharmacokinetic aspects in humans of macrolide antibiotics that are currently or soon to
be on the market (ie erythromycin, oleandomycin, spiramycin, josamycin, midecamycin …
be on the market (ie erythromycin, oleandomycin, spiramycin, josamycin, midecamycin …
New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy
HA Kirst, GD Sides - Antimicrobial agents and chemotherapy, 1989 - Am Soc Microbiol
Erythromycin and related macrolide antibiotics have recently enjoyed a resurgence of
clinical interest. This is a result of activity against organisms which are becoming more …
clinical interest. This is a result of activity against organisms which are becoming more …
The evolution and role of macrolides in infectious diseases
JM Blondeau - Expert Opinion on Pharmacotherapy, 2002 - Taylor & Francis
Two of the most significant changes in the field of infectious disease management during the
last few decades are the emergence of atypical and/or new pathogens that may have …
last few decades are the emergence of atypical and/or new pathogens that may have …
Macrolides: pharmacokinetics and pharmacodynamics
F Van Bambeke, PM Tulkens - International Journal of Antimicrobial Agents, 2001 - Elsevier
Three pharmacokinetic/pharmacodynamic parameters—(i) the peak concentration to the
minimum inhibitory concentration ratio (Cmax/MIC);(ii) the area under the concentration …
minimum inhibitory concentration ratio (Cmax/MIC);(ii) the area under the concentration …
The macrolides.
JM Blondeau, E DeCarolis, KL Metzler… - Expert opinion on …, 2002 - europepmc.org
Erythromycin, which was introduced over 50 years ago, was the first macrolide to be used
clinically." New" macrolides, for the treatment of patients with various infectious diseases …
clinically." New" macrolides, for the treatment of patients with various infectious diseases …
Macrolide antibacterials: drug interactions of clinical significance
NA von Rosenstiel, D Adam - Drug Safety, 1995 - Springer
Macrolide antibiotics can interact adversely with commonly used drugs, usually by altering
metabolism due to complex formation and inhibition of cytochrome P-450 IIIA4 (CYP3A4) in …
metabolism due to complex formation and inhibition of cytochrome P-450 IIIA4 (CYP3A4) in …
Comparative safety of the different macrolides
E Rubinstein - International journal of antimicrobial agents, 2001 - Elsevier
The macrolides are generally well tolerated when used for the treatment of acute infections.
Even when given long term for prophylaxis, there are few discontinuations due to side …
Even when given long term for prophylaxis, there are few discontinuations due to side …
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin
N Bahal, MC Nahata - Annals of Pharmacotherapy, 1992 - journals.sagepub.com
OBJECTIVE: To review the chemistry, antimicrobial spectrum, pharmacokinetics, clinical
trials, adverse effects, and drug interactions of four new macrolide antibiotics: Azithromycin …
trials, adverse effects, and drug interactions of four new macrolide antibiotics: Azithromycin …